| Brand Name | Selexia Biotech |
|---|---|
| Industry | Pharmaceutical & Healthcare |
| Business Category | Pharma Distribution / PCD Franchise |
| Founded Year | 2014 |
| Franchise Started | Expanded through distribution partnerships |
| Total Franchise Outlets | 100–200 |
| Estimated Investment | INR 10,000 – 50,000 |
| Franchise Fee | Typically structured as part of onboarding or product purchase commitment |
| Royalty Fee | Often embedded within product pricing rather than fixed recurring charges |
| Space Requirement | 100–200 sq. ft. |
| Staff Requirement | 1–2 individuals for sales and coordination |
| Expected Payback Period | 1–2 Years |
Selexia Biotech operates in the pharmaceutical distribution sector, offering a portfolio of medicines and healthcare products across multiple therapeutic and consumer categories. The business focuses on supplying products to healthcare professionals, pharmacies, and distributors.
It falls within the broader PCD pharma franchise model, where partners distribute branded pharmaceutical products within assigned territories without engaging in manufacturing.
The business functions as a distribution-based model supported by a product supply network.
Franchise partners promote and supply pharmaceutical products to local markets. The workflow includes building relationships with doctors, retailers, and healthcare providers, followed by order placement and delivery coordination.
Typical operations include:
Revenue is generated through margins earned on product sales.
The product portfolio spans multiple healthcare segments:
| Eye Care Products | Ophthalmic solutions such as antibacterial eye drops |
|---|---|
| Antiseptic Products | Liquids used for hygiene and wound care |
| Injectable Medicines | Products used in clinical and hospital settings |
| Personal Care Products | Medicated shampoos and hygiene-related items |
| Sanitization Products | Hand sanitizers and infection-control solutions |
This diversified range allows franchisees to serve both medical and consumer healthcare markets.
The franchise operates on a territory-based distribution model.
Key elements include:
This structure enables franchisees to build their own network while leveraging an established product base.
The entry cost is relatively low due to the absence of manufacturing requirements.
| Estimated Investment | INR 10,000 to INR 50,000 |
|---|---|
| Franchise Fee | May be included within initial product purchase or onboarding |
| Setup Costs | Basic office or storage setup |
| Inventory Investment | Initial stock procurement |
| Royalty | Typically not charged separately; margins are adjusted within product pricing |
The model is designed for small-scale entry into pharmaceutical distribution.
The infrastructure requirement is minimal and focused on storage and coordination.
Area: 100–200 sq. ft.
Location Preference: Accessible area for distribution and storage
The setup supports a field-driven distribution operation.
Franchise partners typically receive support across product and operational areas.
Support may include:
| Product Knowledge Training | Information on formulations and usage |
|---|---|
| Marketing Materials | Promotional tools for product awareness |
| Supply Chain Support | Timely delivery of products |
| Operational Guidance | Assistance in managing distribution activities |
| Customer Support | Ongoing coordination for order handling |
These systems help franchisees operate efficiently in local markets.
Revenue is generated through product distribution margins.
| Doctor and Pharmacy Network | Expanding connections increases sales |
|---|---|
| Product Range | Multiple categories support consistent demand |
| Repeat Purchases | Medicines and healthcare products have recurring demand |
| Territory Coverage | Wider reach leads to higher volume sales |
Operational costs include inventory purchase, travel, and logistics.
The expected payback period of 1–2 years depends on sales consistency and network development.
Selexia Biotech was established in 2014 and has expanded through a network of distribution partners. The franchise network has grown to over 100 outlets, indicating gradual expansion in regional markets.
Growth strategy includes:
The model combines pharmaceutical distribution with access to both medical and consumer healthcare products. Unlike single-category pharma distributors, it includes a mix of prescription-based and over-the-counter products, enabling franchisees to target multiple customer segments within the same network.
This opportunity may suit:
Investors evaluating this concept may also consider:
These companies operate in the pharmaceutical sector and offer comparable distribution-based business opportunities.
The investment typically ranges from INR 10,000 to INR 50,000. This includes initial stock purchase, basic setup, and operational expenses required to begin pharmaceutical distribution.
The franchise operates through product distribution within a defined territory. Franchisees supply medicines to pharmacies and healthcare providers while managing local marketing and sales activities.
A small space of around 100 to 200 square feet is sufficient. It is mainly used for storing products and handling basic administrative tasks.
The expected payback period is around 1 to 2 years. Recovery depends on sales volume, network expansion, and operational efficiency.
Investors can apply by contacting the company’s franchise team and completing the onboarding process. This typically includes registration, territory allocation, and initiation of product distribution. ## 13. Similar Franchise Opportunities